Viktor Mravcik, Jana Michailidu, Vendula Belackova, et al. – 23 June 2026
The New EU Drugs Strategy: Failure to Consult, Lack of Balance, and Reliance on Outdated Concepts
The article, with contributions from Global Commission on Drug Policy Commissioner Pavel Bém, analyzes the European Union’s new Drugs Strategy and Action Plan Against Drug Trafficking. It examines the strategy’s development process, stakeholder consultation, and the balance between supply reduction measures and public health approaches. The analysis reviews the positioning of harm reduction, consideration of alternative regulatory models, and the continued emphasis on prohibition and law enforcement within the broader context of evolving drug policy approaches.